Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Atran Pharmaceutical Services AB
AB
Active
Org 5591039671
Kungsholms Strand 107, 112 33
Stockholm
All other professional, scientific and technical activities n.e.c.
·
NACE 7499
Est. 2017 · 9 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
Atran Pharmaceutical Services AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
6M
5M
3M
2M
0M
2020: 4M
4M
2020
2021: 4M (0% vs 2020)
4M
0%
2021
2022: 4M (0% vs 2021)
4M
0%
2022
2023: 4M (0% vs 2022)
4M
0%
2023
2024: 5M (+25% vs 2023)
5M
+25%
2024
EBITDA
SEK millions
4M
3M
2M
1M
0M
2020: 1M
1M
2020
2021: 2M (+100% vs 2020)
2M
+100%
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 3M (+50% vs 2023)
3M
+50%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
5 360
4 444
4 319
3 759
3 561
Staff expenses
—
—
—
—
—
EBITDA
3 055
2 068
2 232
1 734
1 237
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
3 055
2 068
2 232
1 734
1 237
Net financials
34
7
—
—
−1
Profit before tax
2 459
1 200
1 070
1 297
923
Tax
−524
−256
−223
−270
−201
Net profit
1 935
944
847
1 027
722
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
7 443
5 229
4 382
4 155
3 289
Equity
3 913
2 578
2 134
2 242
1 715
Long-term debt
0
0
0
0
0
Short-term debt
698
450
382
409
506
Total debt
698
450
382
409
506
Financial ratios
5-year trend
EBITDA margin
57,0 %
This company
15,8 %
Market median
This company
Market median
261% above market
2020
2024
Equity ratio
52,6 %
This company
38,2 %
Market median
This company
Market median
38% above market
2020
2024
Return on equity
49,5 %
This company
18,4 %
Market median
This company
Market median
169% above market
2020
2024
Net profit margin
36,1 %
This company
8,1 %
Market median
This company
Market median
346% above market
2020
2024
Asset turnover
0,72×
This company
1,12×
Market median
This company
Market median
36% below market
2020
2024
Debt / equity
0,90×
This company
0,62×
Market median
This company
Market median
45% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Atran Pharmaceutical Services AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
